Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses:
Research and development expenses	$ 29,431,027	$ 11,254,538
General and administrative expenses	12,241,394	10,184,773
Total operating expenses	41,672,421	21,439,311
Loss from operations	(41,672,421)	(21,439,311)
Interest income (expense), net
Interest income	935,180	4,346
Interest expense	(1,316,519)	0
Interest income (expense), net	(381,339)	4,346
Loss before income taxes	(42,053,760)	(21,434,965)
Benefit from income taxes	1,198,905	4,516,488
Net loss	(40,854,855)	(16,918,477)
Comprehensive loss	$ (40,854,855)	$ (16,918,477)
Per share information:
Net loss per share, basic (in dollars per share)	$ (1.43)	$ (0.66)
Net loss per share, diluted (in dollars per share)	$ (1.43)	$ (0.66)
Weighted average common shares outstanding, basic (in shares)	28,599,221	25,597,125
Weighted average common shares outstanding, diluted (in shares)	28,599,221	25,597,125